The global infusion pump market is evaluated at US$ 7.871 billion for the year 2019 growing at a CAGR of 5.51% reaching the market size of US$11.456 billion by the year 2026.
The infusion pump is a medical device that is used to deliver fluids into a patient’s body to infuse nutrients or medications like insulin, other hormones, antibiotics, and pain relievers. Infusion pumps may be stationary or ambulatory that are designed to be portable or wearable. Different types of infusion pumps like the enteral pump, patient-controlled analgesia (PCA) pump, and insulin pump are used for specialized purposes. Depending on the mechanism used they can be classified into syringe pump, elastomeric pump, peristaltic pump, multi-channel pump, and smart pump. Geographically North America is the largest market for infusion pumps, followed by Europe, Asia-Pacific, and Latin America. The rising prevalence of chronic diseases, increasing healthcare expenditure, and improving healthcare infrastructure are major growth drivers for the market.
The exponential rise in the number of chronic diseases and their corresponding cases has been a significant driver of the market over the years.
The market witnessed exponential growth during the year 2020 owing to the COVID-19 pandemic.
The market is expected to rise during the forecast period owing to the rising rate of obesity, growing genetic factors for type-2 diabetes, and the increasing number of type-1 diabetes patients.
Insulin pumps use is high among the type-1 diabetes population.
|Market size value in 2019||US$7.871 billion|
|Market size value in 2026||US$11.456 billion|
|Growth Rate||CAGR of 5.51% from 2019 to 2026|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Type, Mechanism, Application, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Baxter International Inc., Becton, Dickinson and Company, Braun Melsungen AG, Johnson & Johnson, Medtronic Inc., Nipro Corporation, Option Care Health Inc., Pfizer Inc., Smiths Medical, Terumo Corporation|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What are the growth prospects for the infusion pump market?
A1. The global infusion pump market is projected to grow at a CAGR of 5.51% over the forecast period.
Q2. What is the size of global infusion pump market?
A2. Infusion Pump Market was valued at US$7.871 billion in 2019.
Q3. What will be the infusion pump market size by 2026?
A3. The infusion pump market is projected to reach a market size of US$11.456 billion by 2026.
Q4. Which region holds the largest market share in the infusion pump market?
A4. Geographically North America is the largest market for infusion pumps, followed by Europe, Asia-Pacific, and Latin America.
Q5. What factors are anticipated to drive the infusion pump market growth?
A5. The rising prevalence of chronic diseases, increasing healthcare expenditure, and improving healthcare infrastructure are major growth drivers for the infusion pump market.
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Infusion Pump Market Analysis, by Type
5.2. Insulin Pump
5.3. PCA Pump
5.4. Enteral Pump
6. Infusion Pump Market Analysis, by Mechanism
6.2. Syringe Pump
6.3. Elastomeric pump
6.4. Peristaltic pump
6.5. Multi-channel pump
6.6. Smart Pump
7. Infusion Pump Market Analysis, by Application
7.5. Pain management
8. Infusion Pump Market Analysis, by Geography
8.2. North America
8.3. South America
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.6. Asia Pacific
8.6.4. South Korea
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. Baxter International Inc.
10.2. Becton, Dickinson and Company
10.3. Braun Melsungen AG
10.4. Johnson & Johnson
10.5. Medtronic Inc.
10.6. Nipro Corporation
10.7. Option Care Health Inc.
10.8. Pfizer Inc.
10.9. Smiths Medical
10.10. Terumo Corporation
Baxter International Inc.
Becton, Dickinson and Company
Braun Melsungen AG
Johnson & Johnson
Option Care Health Inc.
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.